Hospital
ST Luke's Hospital
ST Luke's Hospital was paid $4.97M by Medicaid between Apr 2019 and Dec 2024, across 78 billing codes. Its largest line is 99283, emergency room visit (moderate) — 51% of everything it billed.
33Billing provider infoST LUKE'S HOSPITAL
ALLENTOWN, PA 18102
ALLENTOWN, PA 18102
33aNPI1366011413assigned 06/23/2021
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.97M
24GClaims70,568
24DCodes billed78
24AFirst – last monthApr 2019 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#59 of 154
Median peer was paid$2.82M
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 230 | $0.00 | |
| 2020 | 122 | $0.00 | |
| 2021 | 1,368 | $47K | |
| 2022 | 12,923 | $1.29M | |
| 2023 | 16,369 | $1.50M | |
| 2024incomplete | 39,556 | $2.13M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 51% | 13,137 | 12,874 | $2.51M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 27% | 6,826 | 6,707 | $1.34M |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 6.3% | 2,632 | 2,604 | $313K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.2% | 1,248 | 1,231 | $260K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.7% | 3,765 | 3,710 | $236K |
| 80053 | Comprehensive metabolic panel | 1.1% | 5,152 | 5,021 | $53K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,479 | 5,375 | $30K |
| 80061 | Lipid panel | <1% | 2,060 | 2,036 | $26K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 125 | 123 | $23K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 211 | 205 | $17K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,678 | 2,620 | $17K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 549 | 537 | $15K |
66 more codes
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 304 | $12K |
| G0378 | Hospital observation service, per hour | <1% | 15 | $11K |
| 86780 | <1% | 595 | $9K | |
| 86803 | <1% | 432 | $8K | |
| 80050 | General health panel | <1% | 190 | $8K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 222 | $7K |
| 87340 | <1% | 472 | $6K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 521 | $6K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 260 | $6K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 240 | $6K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 240 | $6K |
| 81001 | <1% | 1,988 | $6K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 104 | $5K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 230 | $4K |
| 83690 | <1% | 822 | $4K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 260 | $4K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 327 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 452 | $3K |
| 83735 | <1% | 413 | $3K | |
| 87522 | Neg quan hep c or qual rna | <1% | 58 | $2K |
| 82607 | <1% | 189 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 203 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 219 | $1K |
| 84439 | <1% | 127 | $901.11 | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 12 | $813.76 |
| 82550 | <1% | 139 | $645.32 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 35 | $617.00 |
| 82728 | <1% | 58 | $484.77 | |
| 84484 | <1% | 53 | $428.15 | |
| 83695 | <1% | 26 | $247.25 | |
| 73630 | <1% | 18 | $235.40 | |
| 84550 | <1% | 53 | $198.88 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 24 | $194.40 |
| 86592 | <1% | 39 | $187.20 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13 | $183.05 |
| 82043 | <1% | 30 | $172.23 | |
| 82570 | <1% | 30 | $153.91 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 12 | $86.40 |
| 83540 | <1% | 13 | $65.44 | |
| 83550 | <1% | 13 | $38.73 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,902 | $4.10 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 1,472 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 2,218 | $0.00 |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 445 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 629 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 743 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 364 | $0.00 |
| J3490 | Unclassified drugs | 0% | 152 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 0% | 388 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 37 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 70 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 343 | $0.00 |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 129 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 73 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 586 | $0.00 |
| 90715 | 0% | 49 | $0.00 | |
| J1756 | Injection, iron sucrose, 1 mg | 0% | 1,262 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 2,406 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 77 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 187 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 295 | $0.00 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 0% | 177 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 179 | $0.00 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 34 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 0% | 26 | $0.00 |
| J2426 | Injection, paliperidone palmitate extended release (invega sustenna), 1 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLICHTENWALNER, THOMAS (SENIOR VP FINANCE)
| Provider | Location | Paid |
|---|---|---|
| ST Luke's Hospital | Allentown, PA | $6.98M |
| The Carbon Schuylkill Community Hospital, INC. | Tamaqua, PA | $2.00M |
| ST Luke's Hospital | Lehighton, PA | $1.16M |
| The Carbon-Schuylkill Community Hospital, INC. | Lansford, PA | $758K |
| The Carbon-Schuylkill Community Hospital, INC. | Ringtown, PA | $393K |
| GSLPG, INC | Orwigsburg, PA | $31K |
| ST. Luke's Hospital | Palmerton, PA | $607.60 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.